NewsRoom Articles - Page 120 of 239

WednesdayNov 02, 2022 1:01 pm

Study Finds Covid-19 Spikes Linked to Increases in Heart Attacks

More than two years after the novel coronavirus was first discovered in Wuhan, China, the infectious virus is still wreaking havoc among the global population. Although most countries, with the notable exception of China, have almost wholly loosened their tight pandemic policies, the respiratory disease is still taking lives every day. By mid-September 2022, hundreds of Americans were still losing their lives to COVID, with Centers for Disease Control and Prevention’s director, Dr. Rochelle Walensky, stating that the country was losing up to 375 patients per day due to the virus. Data from the Cedars Sinai Smidt Heart Institute has…

WednesdayNov 02, 2022 9:45 am

India Globalization Capital Inc. (NYSE American: IGC) Is ‘One to Watch’

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC based formulation on Alzheimer’s patients The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. India Globalization Capital (NYSE American: IGC), through subsidiary…

TuesdayNov 01, 2022 11:29 am

Study Finds Epigenetics May Revolutionize Treatment of Cancer

A new study has led to the discovery of new information about the role of epigenetics in cancer development. Epigenetics refers to the study of how an individual’s environment and behaviors cause changes that affect the way their genes work. The study, which was conducted by scientists at the Institute of Cancer Research in London, suggests that dark matter may change the detection and treatment of cancer. It may also facilitate the development of new tests for this illness, which will be useful in tailoring therapies. Prior studies have primarily focused on how structural changes to individual DNA, which cause…

MondayOct 31, 2022 11:16 am

New Research Uncovers Racial Disparities in Treatment of Heart Failure

New research has discovered racial disparities in the provision of treatment for advanced heart failure. The research, which was supported by the National Institutes of Health, found that Black individuals received life-changing treatments almost one-half as often as their White counterparts. Previous research has demonstrated that Black individuals are two times more likely to succumb to heart failure. This is in addition to having a higher risk for experiencing heart failure. For their research, investigators followed 377 patients who received the treatment at a selected center out of the 21 centers in America. White adults made up 277 of the…

FridayOct 28, 2022 9:44 am

Why Food Allergies May Be Increasing

Food allergies have become more common these past few years in both adults as well as children. Allergies are defined as the immune system’s overreaction to an antibody known as immunoglobulin E. This protein is usually produced by the immune system to help detect and attack invaders. When the body identifies a threat, it triggers histamine production, which in turn prompts an allergic reaction in an effort to eliminate the threat. You may notice that when an individual is reacting to something, their skin may itch and their tissues inflame; they may also wheeze, sneeze or cough. Data from the…

ThursdayOct 27, 2022 10:27 am

Researchers Discover New Way to Noninvasively Monitor Immune Cells Inside Tumors

Scientists have designed a new strategy to noninvasively track macrophages in tumors in the breast and brain. Macrophages are immune cells that play a crucial role in the immune system, carrying out a number of functions, including clearing out dead cells and digesting microorganisms. These cells are often recruited by cancer to increase resistance to treatment and support tumor growth. The Ludwig Cancer Research study, led by Davide Croci and Johanna Joyce, also involved their colleague Ruud B. van Heeswijk from the Lausanne University Hospital. Joyce stated that monitoring tumor-associated macrophages had the potential to substantially improve how various cancers…

WednesdayOct 26, 2022 2:48 pm

Study Finds Smart Watches Can Accurately Detect Atrial Fibrillation

New research has found that smart watches can be used to detect atrial fibrillation accurately using an electrocardiogram application. Atrial fibrillation is an irregular heart rhythm that may cause blood clots. It also heightens an individual’s risk of heart failure and stroke, among other heart-related complications. The research, which was conducted earlier this year, discovered that the Apple Watch could be used to diagnose this arrhythmia. For their study, the researchers looked into the accuracy of this device when testing individuals who had abnormal electrocardiograms. The lead author of the study, Dr. Marc Strick, stated that this technology was widely…

TuesdayOct 25, 2022 11:07 am

Researchers Develop Wireless Implant to Kill Cancer Cells in Brain Tumors

Glioblastoma is a deadly and aggressive type of cancer that develops in an individual’s brain or spinal cord. This fatal cancer, which has a 15-month median survival time, claims the lives of more than 10,000 Americans annually. Treatment for brain tumors usually involves surgery to remove as much of the tumor as possible. Surgery is then followed by radiation or chemotherapy, which involves many visits to the hospital and severe side effects. Now, scientists at Stanford Med may have developed a new way to treat brain tumors. They have designed a small wireless implant that can treat patients with brain…

MondayOct 24, 2022 11:18 am

New Experimental Drug May Reverse Brain Damage Caused by Concussions

New research has discovered new information about how an experimental medication reverses neural damage linked to traumatic brain injuries. This discovery lays the foundation for a drug, which could help prevent the cognitive deficit that occurs after a concussion, to be developed in the future. The research was carried out by a team of scientists at the University of California, San Francisco. The primary objective of the research was to explore the integrated stress response signaling pathway. Environmental stresses usually trigger this pathway, often causing facilities that produce proteins in the cells to shut down. For their study, the researchers…

MondayOct 24, 2022 10:30 am

Silo Pharma Inc.’s (NASDAQ: SILO) Novel Ketamine Formulation Undergoing Safety Evaluation, Pursuing Regulatory Pathway

Ketamine used for decades in large doses for surgical anesthesia, low-dose treatments currently prescribed for pain relief, sedation, and treatment-resistant depression Silo’s time-released ketamine formulation SP-26 currently undergoing safety evaluation, study to uncover maximum tolerated dosing data for future trials SP-26 previously reported positive results in reducing neuropathic nerve pain Silo preparing FDA Pre-Investigational New Drug (“IND”) package for SP-26, intends to pursue 505(b)(2) regulatory pathway Ketamine was approved in the United States in 1970 and has been used extensively for surgical anesthesia. Since then, use of the drug in small doses has expanded considerably to treat pain and treatment-resistant…